Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome ; volume:26 ; number:1 ; day:30 ; month:12 ; year:2020 ; pages:1-2 ; date:12.2020
Molecular medicine ; 26, Heft 1 (30.12.2020), 1-2, 12.2020
- Urheber
-
Palmblad, Karin
Schierbeck, Hanna
Sundberg, Erik
Horne, Anna-Carin
Harris, Helena Erlandsson
Henter, Jan-Inge
Antoine, Daniel J.
Andersson, Ulf
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-020-00263-2
- URN
-
urn:nbn:de:101:1-2021020218015707739570
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Palmblad, Karin
- Schierbeck, Hanna
- Sundberg, Erik
- Horne, Anna-Carin
- Harris, Helena Erlandsson
- Henter, Jan-Inge
- Antoine, Daniel J.
- Andersson, Ulf
- SpringerLink (Online service)
Ähnliche Objekte (12)
Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion
Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7
Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC
Retraction Note: microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis
Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
Retraction Note: Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy
Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
HMGB1 in inflammation and cancer
HMGB1, neuronal excitability and epilepsy
Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion
Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7
Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC
Retraction Note: microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis
Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
Retraction Note: Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy
Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
HMGB1 in inflammation and cancer
HMGB1, neuronal excitability and epilepsy
Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion
Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7
Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC
Retraction Note: microRNA-193-3p attenuates myocardial injury of mice with sepsis via STAT3/HMGB1 axis
Retraction Note: Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
Retraction Note: Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy
Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
HMGB1 in inflammation and cancer